NCT06451471View on ClinicalTrials.gov

"Galectin-3 as a Marker of Subclinical Inflammation in FMF"

CompletedOBSERVATIONAL

Enrollment

154

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

November 1, 2022

Study Completion Date

November 1, 2022

Conditions

Ailesel Akdeniz Ateşi

Trial Locations (1)

25240

Ataturk University Faculty of Medicine, Erzurum

All Listed Sponsors

lead

Turkish League Against Rheumatism

OTHER